Composite Scaffolds
Composite scaffolds combine two or more material components. In urinary tissue engineering, examples include a natural matrix or protein combined with a synthetic polymer, or combinations of natural materials. The aim is to balance biological interactions, strength, compliance and degradation.[1][2]
Approaches and limitations
| Approach | Intended benefit | What still needs to be demonstrated |
|---|---|---|
| Layered scaffold or coating | Place different properties at the tissue and urine interfaces | Layers remain bonded, survive suturing and support tissue integration |
| Blended or electrospun materials | Adjust mechanics, surface features and porosity | Reproducibility, suitable degradation and acceptable host response |
| Hydrogel with structural support | Combine a cell-supporting environment with mechanical support | Cell survival, vascularization and a durable urinary barrier |
| 3D printing or bioprinting | Control geometry and spatial placement of materials or cells | Functional tissue maturation and safe, lasting performance after implantation |
These are research strategies.[1][2]
Cell-seeded constructs
Cells may be added to a single-material or composite scaffold. Cultured urothelial cells and smooth-muscle cells are distinct from mesenchymal stromal or other progenitor cells. Cell identity, survival, differentiation and interaction with the host each require assessment.[3]
Clinical interpretation
Experimental bladder augmentation, urethral repair and ureteral replacement should be evaluated separately. Large constructs face particular challenges with perfusion, innervation, urine exposure, fibrosis and mechanical integration.[1][2]
For urethroplasty, the EAU 2026 guideline strongly recommends against using autologous tissue-engineered oral mucosa grafts outside a clinical trial. In the prospective multicentre study of 99 patients that the guideline cites, estimated urethral patency was 67.3% at 12 months and 58.2% at 24 months.[4]
References
1. Sharma S, Basu B. Biomaterials Assisted Reconstructive Urology: The Pursuit of an Implantable Bioengineered Neo-Urinary Bladder. Biomaterials. 2022;281:121331. doi:10.1016/j.biomaterials.2021.121331
2. Duan L, Wang Z, Fan S, Wang C, Zhang Y. Research Progress of Biomaterials and Innovative Technologies in Urinary Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 2023;11:1258666. doi:10.3389/fbioe.2023.1258666
3. Keshel SH, Rahimi A, Hancox Z, et al. The Promise of Regenerative Medicine in the Treatment of Urogenital Disorders. Journal of Biomedical Materials Research. Part A. 2020;108(8):1747–1759. doi:10.1002/jbm.a.36942
4. European Association of Urology. EAU Guidelines on Urethral Strictures. 2026. Chapter 9: Tissue transfer. Guideline text and recommendations.
See also: Decellularized ECM, Synthetic Polymer Scaffolds, Bowel Segments.